Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders

Clinical trial NCT06412653 · COMPLETED

Trial details

NCT number: NCT06412653
Sponsor: Children's University Hospital Cologne, Germany
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

GNAO1 Dystonia Epilepsy Development Delay Developmental and Epileptic Encephalopathy 17 Neurodevelopmental Disorder With Involuntary Movements Choreoathetosis

Start date: 2024-08-02
Primary completion: 2025-08-04
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.